Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | TROP2 CAR/IL-15 TGFBR2 KO NK cells |
| Synonyms | |
| Therapy Description |
TROP2 CAR/IL-15 TGFBR2 KO NK cells are allogeneic, umbilical cord blood-derived natural killer cells engineered to express a chimeric antigen receptor (CAR) targeting TROP2 and with TGFBR2 deleted, which may lead to enhanced anti-tumor response (NCI Thesaurus). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| TROP2 CAR/IL-15 TGFBR2 KO NK cells | Allogeneic anti-TROP2-CAR-IL-15-transduced TGFBR2-KO CB-derived NKs | TROP2 CAR/IL-15 TGFBR2 KO NK cells are allogeneic, umbilical cord blood-derived natural killer cells engineered to express a chimeric antigen receptor (CAR) targeting TROP2 and with TGFBR2 deleted, which may lead to enhanced anti-tumor response (NCI Thesaurus). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07101432 | Phase I | TROP2 CAR/IL-15 TGFBR2 KO NK cells Cyclophosphamide + Fludarabine | Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK) | Active, not recruiting | USA | 0 |